Ark Invest Rebalances: Sells AMD and GOOG While Buying Biotech

Cathie Wood-led Ark Invest executed a portfolio rebalancing Friday, reducing exposure to prominent technology and growth names while expanding positions in biotechnology equities across its exchange-traded fund lineup.

### Portfolio Rebalancing Breakdown Ark Innovation ETF pared holdings in Advanced Micro Devices Inc. ($AMD+WL), Alphabet Inc. ($GOOG+WL), SpaceX, Robinhood Markets Inc. ($HOOD+WL), and Shopify Inc. ($SHOP+WL). Additional fund adjustments included sales of the ARK 21Shares Bitcoin ETF ($ARKB+WL) and DraftKings Inc. ($DKNG+WL) by the ARK Blockchain & Fintech Innovation ETF, alongside reductions in Personalis Inc. ($PSNL+WL) and CareDx Inc. ($CDNA+WL) within the ARK Genomic Revolution ETF ($ARKG+WL).

Conversely, buying activity concentrated heavily within $ARKG+WL, which added positions across multiple biotechnology and gene-editing firms including CRISPR Therapeutics AG ($CRSP+WL) and Intellia Therapeutics Inc. ($NTLA+WL).

### Story Arc / How We Got Here Today's rebalancing follows broader portfolio adjustments across the fund family, building on recent semiconductor momentum noted when Advanced Micro Devices gained 30% during September amid rising demand for CPU hardware and AI application launches, as covered previously in our archive review at /explore/amd-surges-30-percent-september-cpu-demand-ai-launch.

### Money Play If Ark Invest continues rotating capital out of large-cap technology holdings, watch $AMD+WL and $GOOG+WL for institutional repositioning pressure, while monitoring $ARKG+WL for continued biotech accumulation trends.

### Related Names - $AMD+WL - $GOOG+WL - $ARKG+WL